Archives
-
Aminopeptidase Selectivity and ACE Inhibitor Action
2026-09-19
The reference study re-evaluated how bestatin and structurally distinct metallopeptidase inhibitors affect porcine kidney aminopeptidases A, N, and W. Its direct comparison showed that bestatin is relatively weak against AP-N but more active against AP-W, while several non-sulfhydryl ACE inhibitors showed little activity against the aminopeptidases, clarifying how inhibitor selectivity should be interpreted in enzyme and disease-model research.
-
ABT-737: A BCL-2 Protein Inhibitor Workflow
2026-09-18
ABT-737 is a practical BH3 mimetic for testing mitochondrial apoptosis dependence in lymphoma, multiple myeloma, SCLC, and AML models. This workflow combines controlled dosing, orthogonal cell-death readouts, and endogenous BAX/BAK imaging to distinguish genuine pathway engagement from solubility, timing, or overexpression artifacts.
-
Forsythoside E: From Isolation to PKM2 Biology
2026-09-18
The 2009 Molecules study established Forsythoside E as one of the known phenylethanoid glycosides recovered from Forsythia suspensa fruits while introducing three previously undescribed caffeoyl phenylethanoid glycosides. Later mechanistic work has connected Forsythoside E with PKM2 tetramerization, inhibition of macrophage glycolysis, STAT3 phosphorylation suppression, and experimental protection against sepsis-induced liver injury.
-
p-Cresyl Metabolites in Biliary Epithelial Injury
2026-09-17
The reference study shows that p-cresyl sulfate and p-cresyl glucuronide promote apoptosis in human intrahepatic biliary epithelial cells and inflammatory changes in mice. Its paired in vitro and in vivo design connects gut microbial metabolites with hepatobiliary immune injury while identifying measurable histologic, cytokine, and apoptotic endpoints for follow-up research.
-
High Yield T7 Biotin16 RNA Labeling Kit
2026-09-17
The High Yield T7 Biotin16 RNA Labeling Kit is intended for generating biotin-labeled RNA by T7-directed in vitro transcription. The workflow can support RNA detection, capture, and interaction assays, but biotin labeling does not measure m6A or establish the METTL14–SMN mechanism described in the reference study.
-
4-Ethylphenyl Sulfate: Research Workflows
2026-09-16
4-Ethylphenyl sulfate provides a practical bridge between renal metabolite profiling, gut microbiota-brain interaction research, and biomaterial adsorption assays. This guide translates its documented biochemical relevance into reproducible preparation, exposure, surface-binding, and troubleshooting workflows.
-
TMB for P. vivax Serology: Workflow & Tips
2026-09-16
TMB converts HRP-linked immune recognition into a practical colorimetric signal for epitope ELISA, while also supporting tissue staining, enzyme assays, and redox measurements. This guide translates recent Plasmodium vivax epitope findings into an optimized workflow with controls, starting parameters, and troubleshooting guidance.
-
Brassinolide Workflows for Plant and Cancer Research
2026-09-15
Brassinolide connects controlled plant-growth assays with mechanistic apoptosis studies in PC-3 cells and exploratory metabolic research. This guide emphasizes solvent handling, light-aware root assays, quantitative endpoints, and troubleshooting that separates biological activity from formulation or toxicity artifacts.
-
SB 202190: p38 MAP Kinase Inhibitor Workflow
2026-09-15
SB 202190 enables controlled inhibition of p38α/β in inflammation research, cancer therapeutics research, and apoptosis assay workflows. Its value increases when endpoint phospho-signaling measurements are paired with live-cell or single-cell ERK analysis to separate pathway suppression from toxicity and cellular heterogeneity.
-
O-propargyl-puromycin (OPP) Protein Synthesis Assay
2026-09-14
O-propargyl-puromycin (OPP) labels nascent polypeptides through puromycin-mediated translation termination and enables post-labeling detection by azide-alkyne cycloaddition. The reagent provides a practical readout of global protein synthesis for cell biology, proteomics, and mechanistic studies such as Pcbp1-dependent B-cell responses.
-
CCG-1423: A Mechanistic Guide to RhoA Signaling
2026-09-14
Explore how CCG-1423 functions as a RhoA inhibitor through the MRTF-A–importin α/β1 axis. This article presents a decision-focused framework for separating transcriptional, cytoskeletal, barrier, and apoptotic readouts in cancer research and related RhoA/ROCK studies.
-
Uridine, Trisodium Salt for RNA Workflows
2026-09-13
Uridine, Trisodium Salt supports controlled RNA biosynthesis, RNA metabolism studies, and selected vascular assays when its concentration, solvent, and storage history are carefully managed. This guide connects the reagent to PRINT-style RNA-only transgene insertion while clearly separating established findings from workflow recommendations that still require validation.
-
p-Cresyl sulfate in CKD Calcification Models
2026-09-12
Build mechanistic CKD cardiovascular models with p-Cresyl sulfate, linking uremic toxin exposure to endothelial dysfunction and aortic valve calcification. The workflow combines dose-controlled treatment, albumin-aware handling, and orthogonal calcification, viability, and signaling readouts.
-
TMEM16F in Kupffer Cells Protects Against Listeria
2026-09-11
The reference study identifies Kupffer cell, rather than T-cell or B-cell, TMEM16F as a critical determinant of protection during Listeria monocytogenes infection. Its findings connect calcium-activated lipid scrambling and plasma-membrane repair with control of liver inflammation, tissue injury, and metabolic disruption.
-
Forsythoside E for PKM2 Macrophage Studies
2026-09-11
Forsythoside E provides a mechanism-led way to connect PKM2 tetramerization with macrophage metabolism, STAT3 signaling, and inflammatory phenotype. Its defined in vitro range and mouse dosing window support workflows spanning target engagement, macrophage M2 polarization, and sepsis-induced liver injury research.